From: Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study
Toxicity
Number of patients
Hypertension (grade II)
1(5.2%)
Blood diarrhoea (grade III)
Slight epistaxis (grade I)
3(15.8%)